Analyzing Serum-Stimulated Prostate Cancer Cell Lines After Low-Fat, High-Fiber Diet and Exercise Intervention

por Soliman, Sherry, Aronson, William J., Barnard, R. James
Publicado 2011

Effect of Dietary Omega-3 Fatty Acids on Castrate Resistant Prostate Cancer and Tumor Associated Macrophages

por Liang, Pei, Henning, Susanne M., Guan, Johnny, Grogan, Tristan, Elashoff, David, Cohen, Pinchas, Aronson, William J.
Publicado 2019

The Influence of Hepatic Function on Prostate Cancer Outcomes Following Radical Prostatectomy

por Bañez, Lionel L., Loftis, Richard M., Freedland, Stephen J., Presti, Joseph C., Aronson, William J., Amling, Christopher L., Kane, Christopher J., Terris, Martha K.
Publicado 2010

Effects of Calorie Restriction and IGF-1 Receptor Blockade on the Progression of 22Rv1 Prostate Cancer Xenografts

por Galet, Colette, Gray, Ashley, Said, Jonathan W., Castor, Brandon, Wan, Junxiang, Beltran, Pedro J., Calzone, Franck J., Elashoff, David, Cohen, Pinchas, Aronson, William J.
Publicado 2013

Fish Oil Slows Prostate Cancer Xenograft Growth Relative to Other Dietary Fats and is Associated with Decreased Mitochondrial and Insulin Pathway Gene Expression

por Lloyd, Jessica C., Masko, Elizabeth M., Wu, Chenwei, Keenan, Melissa M., Pilla, Danielle M., Aronson, William J., Chi, Jen-Tsan A., Freedland, Stephen J.
Publicado 2013

A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort

por Kuhlmann, Paige K., Oyekunle, Taofik, Klaassen, Zachary, Amling, Christopher L., Aronson, William J., Cooperberg, Matthew R., Kane, Christopher J., Terris, Martha K., Freedland, Stephen J.
Publicado 2023

Validity of the National Death Index to Ascertain the Date and Cause of Death in Men Having Undergone Prostatectomy for Prostate Cancer

por Moghanaki, Drew, Howard, Lauren E., De Hoedt, Amanda, Aronson, William J., Kane, Christopher J., Amling, Christopher L., Cooperberg, Matthew R., Terris, Martha K., Freedland, Stephen J.
Publicado 2019

Phase II Prospective Randomized Trial of Weight Loss Prior to Radical Prostatectomy (PCAN-17-0128)

por Henning, Susanne M, Galet, Colette, Gollapudi, Kiran, Byrd, Joshua B., Liang, Pei, Li, Zhaoping, Grogan, Tristan, Elashoff, David, Magyar, Clara E., Said, Jonathan, Cohen, Pinchas, Aronson, William J.
Publicado 2017

Practice patterns and outcomes of equivocal bone scans for patients with castration-resistant prostate cancer: Results from SEARCH

por Hanyok, Brian T., Everist, Mary M., Howard, Lauren E., De Hoedt, Amanda M., Aronson, William J., Cooperberg, Matthew R., Kane, Christopher J., Amling, Christopher L., Terris, Martha K., Freedland, Stephen J.
Publicado 2019

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy

por Kelkar, Sonia, Oyekunle, Taofik, Eisenberg, Adva, Howard, Lauren, Aronson, William J, Kane, Christopher J, Amling, Christopher L, Cooperberg, Matthew R, Klaassen, Zachary, Terris, Martha K, Freedland, Stephen J, Csizmadi, Ilona
Publicado 2021

Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radi...

por Orabi, Hazem, Howard, Lauren, Amling, Christopher L., Aronson, William J., Cooperberg, Matthew R., Kane, Christopher J., Terris, Martha K., Klaassen, Zachary, Janes, Jessica L., Freedland, Stephen J., Polascik, Thomas J.
Publicado 2022

Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database

por Allott, Emma H., Abern, Michael R., Gerber, Leah, Keto, Christopher J., Aronson, William J., Terris, Martha K., Kane, Christopher J., Amling, Christopher L., Cooperberg, Matthew R., Moorman, Patricia G., Freedland, Stephen J.
Publicado 2013

Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone

por Liu, Sandy, Cadaneanu, Radu M., Zhang, Baohui, Huo, Lihong, Lai, Kevin, Li, Xinmin, Galet, Colette, Grogan, Tristan R., Elashoff, David, Freedland, Stephen J., Rettig, Matthew, Aronson, William J., Knudsen, Beatrice S., Lewis, Michael S., Garraway, Isla P.
Publicado 2016

Predicting bone scan positivity in non-metastatic castration-resistant prostate cancer

por Moreira, Daniel M., Howard, Lauren E., Sourbeer, Katie N., Amarasekara, Hiruni S., Chow, Lydia C., Cockrell, Dillon C., Hanyok, Brian T., Pratson, Connor L., Aronson, William J., Kane, Christopher J., Terris, Martha K., Amling, Christopher L., Cooperberg, Matthew R., Liede, Alexander, Freedland, Stephen J.
Publicado 2015

Systemic and tumor-directed therapy for oligometastatic prostate cancer: study protocol for a phase II trial for veterans with de novo oligometastatic disease

por Parikh, Neil R., Huiza, Claudia, Patel, Jill S., Tsai, Sonny, Kalpage, Nathisha, Thein, May, Pitcher, Sage, Lee, Steve P., Inouye, Warren S., Jordan, Mark L., Sanati, Homayoon, Jafari, Lida, Bennett, Carol J., Gin, Greg E., Kishan, Amar U., Reiter, Robert E., Lewis, Michael, Sadeghi, Ahmad, Aronson, William J., Garraway, Isla P., Rettig, Matthew B., Nickols, Nicholas G.
Publicado 2019

MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer

por Nickols, Nicholas G., Nazarian, Ramin, Zhao, Shuang G., Tan, Victor, Uzunangelov, Vladislav, Xia, Zheng, Baertsch, Robert, Neeman, Elad, Gao, Allen C., Thomas, George V., Howard, Lauren, De Hoedt, Amanda M., Stuart, Josh, Goldstein, Theodore, Chi, Kim, Gleave, Martin E., Graff, Julie N., Beer, Tomasz M., Drake, Justin M., Evans, Christopher P., Aggarwal, Rahul, Foye, Adam, Feng, Felix Y., Small, Eric J., Aronson, William J., Freedland, Stephen J., Witte, Owen N., Huang, Jiaoti, Alumkal, Joshi J., Reiter, Robert E., Rettig, Matthew B.
Publicado 2019